JP2019537559A5 - - Google Patents

Download PDF

Info

Publication number
JP2019537559A5
JP2019537559A5 JP2019517991A JP2019517991A JP2019537559A5 JP 2019537559 A5 JP2019537559 A5 JP 2019537559A5 JP 2019517991 A JP2019517991 A JP 2019517991A JP 2019517991 A JP2019517991 A JP 2019517991A JP 2019537559 A5 JP2019537559 A5 JP 2019537559A5
Authority
JP
Japan
Prior art keywords
compound
nrr
formula
pyridin
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019517991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019537559A (ja
JP7089141B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/054668 external-priority patent/WO2018067422A1/en
Publication of JP2019537559A publication Critical patent/JP2019537559A/ja
Publication of JP2019537559A5 publication Critical patent/JP2019537559A5/ja
Application granted granted Critical
Publication of JP7089141B2 publication Critical patent/JP7089141B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019517991A 2016-10-03 2017-09-30 新規なjak1選択的阻害剤およびその使用 Active JP7089141B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662403660P 2016-10-03 2016-10-03
US62/403,660 2016-10-03
PCT/US2017/054668 WO2018067422A1 (en) 2016-10-03 2017-09-30 Novel jak1 selective inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2019537559A JP2019537559A (ja) 2019-12-26
JP2019537559A5 true JP2019537559A5 (https=) 2021-03-04
JP7089141B2 JP7089141B2 (ja) 2022-06-22

Family

ID=61831161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019517991A Active JP7089141B2 (ja) 2016-10-03 2017-09-30 新規なjak1選択的阻害剤およびその使用

Country Status (19)

Country Link
US (3) USRE50799E1 (https=)
EP (1) EP3509591B1 (https=)
JP (1) JP7089141B2 (https=)
KR (1) KR102399848B1 (https=)
CN (2) CN113214278B (https=)
AU (3) AU2017339417C1 (https=)
DK (1) DK3509591T3 (https=)
EA (1) EA201990523A1 (https=)
ES (1) ES2901216T3 (https=)
HK (1) HK1253040A1 (https=)
HR (1) HRP20211965T1 (https=)
HU (1) HUE058120T2 (https=)
IL (3) IL265358B (https=)
MX (1) MX390005B (https=)
NZ (1) NZ751284A (https=)
PL (1) PL3509591T3 (https=)
PT (1) PT3509591T (https=)
RS (1) RS62695B1 (https=)
WO (1) WO2018067422A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102399848B1 (ko) 2016-10-03 2022-05-19 하이라이트ll 파머슈티컬 (하이난) 컴퍼니, 리미티드 신규한 jak1 선택적 억제제 및 그 용도
PL3568396T3 (pl) 2017-01-11 2021-05-31 Leo Pharma A/S Nowe pochodne aminoimidazopirydyny jako inhibitory kinaz janusowych i ich zastosowanie farmaceutyczne
CA3117969A1 (en) 2018-10-31 2020-05-07 Incyte Corporation Combination therapy for treatment of hematological diseases
MA55201A (fr) * 2019-03-05 2022-01-12 Incyte Corp Inhibiteurs de la voie jak1 pour le traitement d'un dysfonctionnement chronique de l'allogreffe pulmonaire
US11624751B2 (en) 2019-03-19 2023-04-11 Incyte Corporation Biomarkers for vitiligo
IL318796A (en) * 2019-06-06 2025-04-01 Hangzhou Highlightll Pharmaceutical Co Ltd Method for preparing a furoimidazopyridine compound, polymorph and salt polymorph
KR102785014B1 (ko) * 2019-06-06 2025-03-20 항저우 하이라이트엘엘 파마슈티컬 씨오., 엘티디. 푸로이미다조피리딘 화합물의 합성 방법, 푸로이미다조피리딘 화합물의 결정 형태, 및 그의 염의 결정 형태
CN115803317B (zh) 2020-05-19 2025-07-15 拜耳作物科学股份公司 作为杀真菌化合物的氮杂双环(硫代)酰胺
WO2021249995A1 (en) 2020-06-10 2021-12-16 Bayer Aktiengesellschaft Azabicyclyl-substituted heterocycles as fungicides
EP4351584A4 (en) * 2021-06-07 2025-04-23 The Regents of the University of California COMPOSITIONS AND METHODS FOR TREATING CELIAC DISEASE
EP4419101A4 (en) * 2021-09-13 2025-09-03 Hangzhou Highlightll Pharmaceutical Co Ltd METHODS OF TREATMENT OF CNS DISORDERS
CN114213424B (zh) 2021-12-30 2023-05-26 杭州高光制药有限公司 一种呋喃[3,2-b]并吡啶衍生物的合成方法
WO2025224600A1 (en) * 2024-04-21 2025-10-30 Biohaven Therapeutics Ltd. Treatment of alpha-synucleinopathies and neuroprotection
WO2025248468A1 (en) 2024-05-28 2025-12-04 Biohaven Therapeutics Ltd. Use of tyk2/jak1 inhibitors to treat amyloid-related imaging abnormalities (aria)
WO2026002028A1 (zh) * 2024-06-26 2026-01-02 杭州多域生物技术有限公司 稠杂芳环类化合物、其药物组合物及其应用
WO2026032213A1 (zh) * 2024-08-08 2026-02-12 普罗思特(南京)生物科技有限公司 取代的三环衍生物及其应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983092A (en) 1975-01-20 1976-09-28 Ciba-Geigy Corporation Phenylindane diamine mixture and epoxy resin therewith
US4369172A (en) 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3583799D1 (de) 1985-01-11 1991-09-19 Abbott Lab Ltd Feste zubereitung mit langsamer freisetzung.
JP2773959B2 (ja) 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
DE69924735T2 (de) 1998-07-28 2006-01-19 Tanabe Seiyaku Co., Ltd. Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
JP2000119271A (ja) 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd 1h―イミダゾピリジン誘導体
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US6800663B2 (en) 2002-10-18 2004-10-05 Alkermes Controlled Therapeutics Inc. Ii, Crosslinked hydrogel copolymers
US20070185152A1 (en) 2004-03-02 2007-08-09 Smithkline Beecham Corporation Inhibitors of akt activity
CN101282974A (zh) * 2005-08-04 2008-10-08 西特里斯药业公司 作为sirtuin调节剂的咪唑并吡啶衍生物
CN101238186B (zh) 2005-08-11 2012-10-24 3M创新有限公司 作为金属基底涂层的互穿聚合物网络及其制造方法
WO2007039146A1 (en) 2005-09-23 2007-04-12 Smithkline Beecham Corporation 4-carboxy pyrazole derivatives as anti-viral agents
US7879968B2 (en) 2006-10-17 2011-02-01 Taylor Made Golf Company, Inc. Polymer compositions and golf balls with reduced yellowing
US20100280151A1 (en) 2009-05-04 2010-11-04 Toray Industries, Inc. Toughened fiber reinforced polymer composite with core-shell particles
KR20120081164A (ko) * 2009-09-29 2012-07-18 엑스커버리 홀딩 컴퍼니 엘엘씨 Pi3k(델타) 선택적 억제제
WO2011138657A1 (en) 2010-05-04 2011-11-10 Glenmark Pharmaceuticals S.A. Aryl substituted olefinic compounds as pde10a inhibitors
WO2012022045A1 (en) * 2010-08-20 2012-02-23 Hutchison Medipharma Limited Pyrrolopyrimidine compounds and uses thereof
RU2013120966A (ru) 2010-10-08 2014-11-20 Эббви Инк. ФУРО[3,2-d]ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ
WO2013007768A1 (en) 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
AU2012295802B2 (en) 2011-08-12 2017-03-30 Nissan Chemical Industries, Ltd. Tricyclic heterocyclic compounds and JAK inhibitors
JP6057907B2 (ja) 2011-10-04 2017-01-11 株式会社ヤクルト本社 チアゾリジン誘導体又はその塩を有効成分とする医薬品
CN104918945B (zh) 2012-11-01 2018-01-05 因赛特公司 作为jak抑制剂的三环稠合噻吩衍生物
CN103450125B (zh) 2013-07-18 2016-01-13 嘉兴中科化学有限公司 一种5-取代苯丙呋喃-2-羧酸及其衍生物的合成方法
EP3060234A1 (en) 2013-10-24 2016-08-31 AbbVie Inc. Jak1 selective inhibitor and uses thereof
CN106687462A (zh) 2014-04-30 2017-05-17 因赛特公司 Jak1抑制剂的制备方法以及其新形式
EP2940022B1 (en) 2014-04-30 2020-09-02 Masarykova Univerzita Furopyridines as inhibitors of protein kinases
US9498467B2 (en) 2014-05-30 2016-11-22 Incyte Corporation Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
CN105418620B (zh) 2014-09-23 2018-05-04 天津药明康德新药开发有限公司 一种4-(叔丁氧羰基)八氢呋喃并[3,2-b]吡啶-6-羧酸的合成方法
WO2016100349A2 (en) 2014-12-16 2016-06-23 Rugen Holdings (Cayman) Limited Bicyclic azaheterocyclic compounds as nr2b nmda receptor antagonists
WO2016196244A1 (en) 2015-05-29 2016-12-08 Incyte Corporation Pyridineamine compounds useful as pim kinase inhibitors
CN106432232A (zh) 2016-09-18 2017-02-22 苏州汉德创宏生化科技有限公司 1‑哌啶‑4‑基‑1,3‑二氢‑咪唑[4,5‑b]吡啶‑2‑酮的合成方法
KR102399848B1 (ko) 2016-10-03 2022-05-19 하이라이트ll 파머슈티컬 (하이난) 컴퍼니, 리미티드 신규한 jak1 선택적 억제제 및 그 용도
LT3555097T (lt) 2016-12-16 2022-08-25 Janssen Pharmaceutica Nv Imidazo[4,5-d]pirolo[2,3-b]piridino junginiai kaip janus kinazės inhibitoriai
CN107216334A (zh) 2017-06-29 2017-09-29 上海吉尔多肽有限公司 一种6‑氯呋喃[3,2‑b]吡啶的合成方法
KR102785014B1 (ko) 2019-06-06 2025-03-20 항저우 하이라이트엘엘 파마슈티컬 씨오., 엘티디. 푸로이미다조피리딘 화합물의 합성 방법, 푸로이미다조피리딘 화합물의 결정 형태, 및 그의 염의 결정 형태
IL318796A (en) 2019-06-06 2025-04-01 Hangzhou Highlightll Pharmaceutical Co Ltd Method for preparing a furoimidazopyridine compound, polymorph and salt polymorph
CN118619944A (zh) 2019-06-06 2024-09-10 北京泰德制药股份有限公司 作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物
CN114213424B (zh) 2021-12-30 2023-05-26 杭州高光制药有限公司 一种呋喃[3,2-b]并吡啶衍生物的合成方法

Similar Documents

Publication Publication Date Title
JP2019537559A5 (https=)
HRP20211965T1 (hr) Novi selektivni inhibitori jak1 i njihova upotreba
JP2006503888A5 (https=)
RU2012132278A (ru) Трициклические гетероциклические соединения, содержащие их композиции и способы их применения
JP2017519754A5 (https=)
CA2894016A1 (en) Modulators of the retinoid-related orphan receptor gamma (ror-gamma) for use in the treatment of autoimmune and inflammatory diseases
JP2017504576A5 (https=)
JP2015508092A5 (https=)
JP2019504840A5 (https=)
EP3059227A1 (en) Nitrogen-containing heterocyclic compound salt or crystal thereof, pharmaceutical composition, and flt3 inhibitor
JP2017508733A5 (https=)
JP2017519796A5 (https=)
JP2021500340A (ja) PI3K−γ阻害剤としての三級ヒドロキシ基で置換された縮合イミダゾール誘導体
CA2958625A1 (en) Crystal of pyrrole derivative and method for producing the same
JP2009538910A5 (https=)
JP2016531868A5 (https=)
JP2011517443A5 (https=)
RU2018103332A (ru) Пиримидиновое соединение с конденсированными кольцами, его промежуточное соединение, способ получения, композиция и применение
MX2015004467A (es) Proceso para preparar compuestos tienopirimidinas.
MX2021014320A (es) Metodo para sintetizar el compuesto de furoimidazopiridina, sustancia polimorfica y sustancia polimorfica de sal.
JP2015502371A5 (https=)
MX354815B (es) Derivados heterociclicos como receptores asociados con las aminas traza (taars).
JP2007500168A5 (https=)
MX2016016488A (es) Derivados de azetidina sustituidos como ligandos de receptores asociados a aminas en trazas (taar).
JP2009504771A5 (https=)